Compounded Semaglutide Cost: Real Prices (2026)

Telehealth compounded semaglutide programs list entry prices from $99 to $199 per month in our provider database as of September 11, 2026; compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Strut Health and HealthRx start at $99 (HealthRx on its 12-month plan; $133 on its 3-month plan), SkinnyRx at $149.25, Shed at $159 on a 12-month term, TrimRx and MEDVi at $179 (MEDVi for your first month; its site says refills are locked in at $299), and Sprout Health at $199. Two pricing realities to check before subscribing: first, an advertised rate can depend on plan term (the lowest HealthRx and Shed rates require 12-month plans), and titration can raise your dose and sometimes your price; second, the first month can be priced lower than the refills. The benchmark to compare against is brand-name Wegovy through NovoCare Pharmacy, the manufacturer self-pay channel: $349 per month for 0.25mg to 2.4mg and $399 for Wegovy HD 7.2mg, after $199 per month for your first two fills if you are new to the offer (through December 31, 2026). Re-checked September 11, 2026; confirm current pricing at checkout. A $179 compounded month saves you $170 against the $349 NovoCare price, which is real but far smaller than a comparison against the $1,349.02 original price suggests.

It can be, but compounded semaglutide is not FDA-approved. The FDA says compounded drugs should only be used when your medical needs cannot be met by an FDA-approved drug, and that a compounded drug might be appropriate when the FDA-approved drug is not commercially available. The FDA also lists warning signs for telehealth programs, including claims that a compounded drug is the same as an FDA-approved drug, prices that seem too good to be true, no screening and prescription by a licensed doctor, and no licensed doctor available to answer questions after you receive your medication. The practical questions for you are whether a licensed US prescriber evaluates you individually, whether the program names its state-licensed pharmacy, and whether a licensed doctor is available once treatment starts.

Nobody can tell you that with trial evidence, because compounded semaglutide has not been studied the way Wegovy was. The 14.9% average body weight loss over 68 weeks in the STEP 1 trial (individual results vary), published in the New England Journal of Medicine, was measured on semaglutide 2.4mg made by Novo Nordisk, not on compounded products, and compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. Brand Wegovy comes in fixed-dose pens made under FDA manufacturing oversight; compounded semaglutide depends on the individual pharmacy preparing it accurately. The FDA has also received reports of dosing errors with compounded semaglutide in multiple-dose vials, in some cases five to 20 times the intended dose. If you and your provider consider a compounded program, ask it to name its licensed pharmacy and give you precise administration instructions.

Because you are paying for different things. Brand Wegovy is an FDA-approved product made by Novo Nordisk in prefilled pens, while compounded semaglutide, which is not FDA-approved, is prepared by pharmacies, dispensed in multiple-dose vials or prefilled syringes according to the FDA, and sold through telehealth programs. The gap is smaller than list prices suggest. Against the $1,349.02 original price listed on TrumpRx, compounded entry prices look over $1,000 cheaper, but Novo Nordisk sells Wegovy self-pay through NovoCare at $349 per month for 0.25mg to 2.4mg and $399 for Wegovy HD 7.2mg (re-checked September 11, 2026). Against that, compounded entry prices of $99 to $199 save you $150 to $250 a month, and a $299 refill saves you $50. That is why the smarter comparison for your budget is compounded versus NovoCare, and why programs priced near $300 face a hard question about what you are getting for near-brand money.

Compounded semaglutide is not FDA-approved, and five questions filter the field quickly. First, which licensed US pharmacy fills the prescription, and in which state? Legitimate programs answer immediately; evasion is disqualifying. Second, what is the full dose-price schedule through month six, including escalation, so the advertised starting price cannot surprise you later. Third, what exact administration instructions and syringe guidance come with each dose change, given documented FDA reports of multi-fold dosing errors with compounded vials. Fourth, what happens to your treatment if compounding rules tighten again, and whether the program offers a transition path to branded product like NovoCare Wegovy at $349-$399 per month (re-checked September 11, 2026). Fifth, who evaluates you clinically, at intake and ongoing, and how fast the provider responds when you report side effects. Any program that answers all five cleanly is treating you as someone in its care; a program that stumbles on most of them is treating you as a subscription.

Possibly, but confirm with your HSA or FSA plan administrator before you pay, because eligibility for compounded medication, which is not FDA-approved, and for program fees can vary by plan. If you pay out of pocket, keep an itemized receipt showing the prescription, the provider, and the amounts so you can submit it for reimbursement.

In our provider database as of September 11, 2026, Strut Health and HealthRx share the low end at $99 per month (HealthRx on its 12-month plan; $133 on its 3-month plan), followed by SkinnyRx at $149.25, Shed at $159 on a 12-month term, TrimRx and MEDVi at $179 (MEDVi for your first month; its site says refills are locked in at $299), and Sprout Health at $199; all are compounded programs, not FDA-approved and not reviewed by the FDA for safety, effectiveness, or quality. Before choosing purely on the headline number, verify three things that change the real ranking. First, the steady-state price after the first month and after dose escalation, because programs differ in how much refills and higher doses cost. Second, what the subscription actually includes: a low monthly rate that bills labs and follow-ups separately can end up costing more than it looks. Third, plan length, refill flexibility and cancellation terms, since the lowest rates at HealthRx and Shed require a 12-month plan. The cheapest program is the one with the lowest six-month total for your dose, not the lowest first-month banner price.

Prices span $99 to $199 at entry, and more after the first month at some programs, for a few reasons: which compounding pharmacy the program contracts with; how much clinical service is bundled, from bare prescription renewal up to responsive providers, dose management, and side effect support; plan length, since HealthRx and Shed charge less per month on a 12-month plan; and dose, since some programs price higher doses above the starting rate. What price does not reliably signal is medication quality. A $99 program and a $199 program may use equally reputable pharmacies, and a mid-priced program may use a weaker one. None of these compounded products is FDA-approved, so judge quality directly: ask which licensed US pharmacy fills the prescription, confirm its state license, and evaluate how the program handled your intake questions. Pay more only for service you will actually use, not for the assumption that expensive means safer.

Annual totals at 12 monthly payments of the entry price, before any dose-based price changes: $1,188 at Strut Health or HealthRx on its 12-month plan ($99/month), $1,791 at SkinnyRx ($149.25/month), $1,908 at Shed on a 12-month term ($159/month), $2,148 at TrimRx ($179/month), $2,388 at Sprout Health ($199/month), and $3,468 at MEDVi ($179 for the first month, then 11 refills at the $299 its site lists). All of these are compounded programs; compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. The branded comparison: Novo Nordisk defines a Wegovy month as one box of 4 weekly pens, so a year of treatment takes 13 boxes. At the $349 NovoCare price that is $4,537 a year ($4,237 if your first two fills are at $199), and $5,187 at the $399 Wegovy HD price. Covered commercial insurance with the savings offer can cost as little as $25 per box. Two things belong in an honest annual budget. First, monitoring: ask whether your program bills labs or follow-up visits separately. Second, duration: the STEP 1 extension study reported that participants regained much of their lost weight within a year of stopping semaglutide, so budget for the possibility of multi-year treatment if you and your provider continue it, and compare on that basis against the branded routes or intensive lifestyle programs, not as a single-year expense that simply ends.

We have no verified prices for oral or sublingual compounded semaglutide in our September 2026 checks, so we cannot tell you it is cheaper. For an FDA-approved oral option, the Wegovy pill costs $149 per month for 1.5mg, $199 for 4mg and $299 for 9mg and 25mg through NovoCare. The clinical tradeoff matters more than the price difference. Oral semaglutide absorbs far less efficiently than injection: FDA-approved oral semaglutide such as Rybelsus (approved for type 2 diabetes) uses a specialized absorption enhancer and still delivers a small fraction of an injected dose, and compounded sublingual drops and troches, which are not FDA-approved, lack the absorption data behind the approved tablets. Published weight loss evidence, including the 14.9% STEP 1 result, comes overwhelmingly from once-weekly subcutaneous injection. If needle aversion is the obstacle, ask your provider to compare the FDA-approved Wegovy pill and an injectable before you consider a compounded sublingual with limited evidence, and weigh the evidence gap more heavily than a small monthly price difference.